Quintara Discovery

News

9/15/2015 – Quintara Discovery is awarded a 5 year contract by the NIH (National Institutes of Health) with a maximum potential value of $20 million that is being shared with several other companies. Under this contract (HHSN271201500026I), Quintara Discovery will provide extensive bioanalysis testing services to the NCATS for their various therapeutic projects. The scope will include CYP450 interaction, metabolic stability (microsomes, S9 and hepatocyte), permeability, plasma protein binding, solubility, LogD, reaction phenotyping, metabolite identification, PK bioanalysis and RapidFire-related assays.